Table 3 The expression profile of LILRB1 mRNA and clinicopathological glioma risk variables in our clinical data
Characteristics | Low expression of LILRB1 | High expression of LILRB1 | P value |
|---|---|---|---|
n | 19 | 19 | Â |
WHO grade, n (%) |  |  | < 0.001 |
 G2 | 11 (28.9%) | 0 (0%) |  |
 G3 | 2 (5.3%) | 1 (2.6%) |  |
 G4 | 6 (15.8%) | 18 (47.4%) |  |
IDH status, n (%) | Â | Â | 0.007 |
 Mut | 12 (31.6%) | 3 (7.9%) |  |
 WT | 7 (18.4%) | 16 (42.1%) |  |
Gender, n (%) | Â | Â | 1.000 |
 Female | 9 (23.7%) | 9 (23.7%) |  |
 Male | 10 (26.3%) | 10 (26.3%) |  |
Age, n (%) | Â | Â | 0.079 |
 > 60 | 3 (7.9%) | 9 (23.7%) |  |
 <=60 | 16 (42.1%) | 10 (26.3%) |  |